Track the Jubilant Ingrevia share price and the full insider trade history of the company, a listed issuer based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €107.1bn. The latest transaction was reported on 30 June 2026 (Pledge). Among the most active insiders: HSB Trustee Company Private Ltd and HS Trustee Company Pvt Ltd. All data is accessible without an account.
Analysts rate Jubilant Ingrevia Strong Buy (bullish), based on 6 analysts. Average price target: ₹939.50.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Jubilant Ingrevia is a company specializing in the manufacturing of chemicals and solutions for various sectors. It primarily operates in the Indian market and focuses on innovation and sustainability.